View Older Stories View More Recent Stories

May 30, 2025 09:00AM Atropos Health Continues Commitment to Advancements in Oncology with Addition of Key Personnel
May 30, 2025 09:00AM Myeloid Therapeutics Unveils First-in-Human In Vivo mRNA CAR Data, Marking a Breakthrough in RNA-Based Immuno-Oncology at the 2025 ASCO Annual Meeting
May 30, 2025 09:00AM Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 30, 2025 09:00AM MySize Inc. Appointed Borja Cembrero Saralegui as Chief Growth Officer to Accelerate Global Expansion and Circular Fashion Strategy
May 30, 2025 08:36AM vybe urgent care announces its 16th greater Philadelphia location in Brookhaven
May 30, 2025 08:31AM XRP News: Nimanode’s $NMA Presale Demand Surges, Positions For Explosive Growth
May 30, 2025 08:30AM OncoHost Study Offers New Insights Into Resistance Mechanisms in Immunotherapy-Treated Lung Cancer Patients
May 30, 2025 08:30AM ESGold Launches Final Concentration Tests Ahead of First Production at Montauban
May 30, 2025 08:16AM Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal
May 30, 2025 08:15AM ReElement Technologies Joins Ivy Tech Community College as Workforce Development Partner Through U.S. Department of Labor Apprenticeship Grant
May 30, 2025 08:05AM Merck (MRK) Announces MK-1084 Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
May 30, 2025 08:05AM Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbo
May 30, 2025 08:01AM Merck's (MRK) Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate
May 30, 2025 08:00AM Mega Matrix Corp (MPU) Board Approves Bitcoin and Ethereum as Treasury Reserve Asset
May 30, 2025 08:00AM Merck’s Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBC
May 30, 2025 08:00AM NCR Atleos Ranked #12 on Newsweek’s List of the 2025 Top 100 Global Most Loved Workplaces®
May 30, 2025 08:00AM Upexi to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24-25
May 30, 2025 08:00AM Recursion to Participate in Upcoming Investor Conferences
May 30, 2025 08:00AM Mega Matrix Inc. Board of Directors Approves Bitcoin and Ethereum as Treasury Reserve Asset
May 30, 2025 08:00AM AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
May 30, 2025 08:00AM Restive Ventures Opens Applications for 9th Fintech Founder Cohort
May 30, 2025 07:50AM TRU Updates US Exchange Listing
May 30, 2025 07:30AM TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
May 30, 2025 07:30AM TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
May 30, 2025 07:30AM Serve Robotics to Hold Annual Meeting of Stockholders on June 12, 2025
May 30, 2025 07:30AM Criterium Energy Announces Filing of Q1 2025 Financial Results and Provides Operational Update
May 30, 2025 07:03AM Paycheck-to-Paycheck to Financial Freedom: Bitcoin Solaris Opens Mobile Mining Access Ahead of Nova App Launch
May 30, 2025 07:01AM Cartesian Therapeutics (RNAC) Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
May 30, 2025 07:00AM BioLineRx (BLRX) to Present New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide
May 30, 2025 07:00AM Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
May 30, 2025 07:00AM Wesco Earns 2025 Great Place To Work Certification™
May 30, 2025 07:00AM Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025
May 30, 2025 07:00AM Cathedra Bitcoin Announces First Quarter 2025 Financial Results
May 30, 2025 07:00AM BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting
May 30, 2025 06:50AM Bitget Partners with Kronos Research to Deliver Institutional-Grade Liquidity and Trading Efficiency
May 30, 2025 04:11AM VEEPEEN Launches with Viral Momentum, Crosses 3,000 Holders Amid VEEPEEN Meme Surge
May 30, 2025 03:00AM ‘Unlucky Charm’: Heineken® and Self-Confessed Jinx Go to Extreme Lengths to Protect the Result at 2025 UEFA Champions League Final
May 30, 2025 03:00AM ‘Unlucky Charm’: Heineken® and Self-Confessed Jinx Go to Extreme Lengths to Protect the Result at 2025 UEFA Champions League Final
May 30, 2025 02:15AM Alchemy Pay Integrates USD1 On-Ramp, Expanding Stablecoin Access with World Liberty Financial
May 29, 2025 07:37PM ROSEN, NATIONAL TRIAL COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
May 29, 2025 07:28PM CERE DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Clas
May 29, 2025 07:11PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV
May 29, 2025 06:51PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DNUT
May 29, 2025 06:48PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NSSC
May 29, 2025 06:27PM ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
May 29, 2025 06:15PM Loop Industries Reports Fourth Quarter and Full Year Fiscal 2025 Results and Provides Update on Business Developments
May 29, 2025 06:12PM BKKT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important June 2 Deadline in Securities Class Action - BKKT
May 29, 2025 06:10PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CODI
May 29, 2025 05:53PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Digimarc Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMRC
May 29, 2025 05:48PM CGC DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CGC
View More Recent Stories View Older Stories